Presentations From prIME Masterclass in Colorectal Cancer
prIME Downloadable Slides
prIME Downloadable Slides

Presentations From prIME Masterclass in Colorectal Cancer

A Multidisciplinary Interactive Workshop

Not a member of My prIME? Join now for instant access.

Improve your understanding of colorectal cancer (CRC) with insights from the experts on biomarker testing, a multidisciplinary treatment approach, and optimal treatment options for metastatic CRC (mCRC) in the first-line setting and beyond.

Downloadable Slides

Downloadable Slides

IME

IME

Release Date

Release Date

Jul 15, 2017

Expiration Date

Jul 15, 2018

Featured Expert

  • Claus-Henning Köhne, MD, Klinikum Oldenburg, Oldenburg, Germany

Featured Topic

Keynote presentation—Personalized therapy for CRC in 2017: Accomplishments, challenges, and opportunities

Featured Expert

  • Graeme Poston, MD, FRCS, Aintree University Hospital, Liverpool, United Kingdom

Featured Topic

Multidisciplinary treatment of CRC in practice: Role of a multidisciplinary team in managing synchronous liver metastases in colon and rectal cancer

Featured Expert

  • Takayuki Yoshino, MD, PhD, National Cancer Center Hospital East, Chiba, Japan

Featured Topic

Multidisciplinary treatment of CRC in practice: Managing stage II and III colon

Featured Expert

  • Kun-Huei Yeh, MD, PhD, National Taiwan University Hospital, National Taiwan University Cancer Center, Taipei, Taiwan

Featured Topic

Optimizing sequential therapy in mCRC: Selecting first-line therapy

Featured Expert

  • Kei Muro, MD, Aichi Cancer Center Hospital, Nagoya, Japan

Featured Topic

Optimizing sequential therapy in mCRC: Continuum of care in mCRC (second and later treatment lines)

Featured Expert

  • Claus-Henning Köhne, MD, Klinikum Oldenburg, Oldenburg, Germany

Featured Topic

Optimizing sequential therapy in mCRC: BRAF-mutant mCRC

Featured Expert

  • Takayuki Yoshino, MD, PhD, National Cancer Center Hospital East, Chiba, Japan

Featured Topic

What is the role of immunotherapy in CRC?

Featured Expert

  • Ming-Huang Chen, MD, PhD, Taipei Veterans General Hospital, Taipei, Taiwan

Featured Topic

Treatment of  Advanced Sigmoid Colon  Cancer With Extensive Liver Metastases

Featured Expert

  • Shuntaro Yoshida, MD, PhD, The University of Tokyo, Tokyo, Japan

Featured Topic

Issues in Colorectal Liver Metastases

Featured Expert

  • Yi-Hsin Liang, MD, National Taiwan University Hospital, Taipei, Taiwan

Featured Topic

Combination of Localized and Systemic Treatment for RAS Wildtype Metastatic Colorectal Cancer

Featured Expert

  • Atsuo Takashima, MD, PhD, National Cancer Center Hospital, Tokyo, Japan

Featured Topic

A Case of Locally Advanced Rectal Cancer

Featured Expert

  • Claus-Henning Köhne, MD, Klinikum Oldenburg, Oldenburg, Germany
  • Takayuki Yoshino, MD, PhD, National Cancer Center Hospital East, Chiba, Japan

Featured Topic

prIME Points™

This educational activity is specifically designed to meet the needs of oncologists, registered nurses, and other healthcare professionals involved in the treatment of patients with CRC.

After successful completion of this educational activity, participants should be able to:

  • Explain current recommendations for biomarker testing to guide targeted therapy and advanced personalized care for patients with CRC
  • Identify the importance of a multidisciplinary treatment approach for patients with early and metastatic CRC
  • Select optimal treatment options for mCRC in the first-line setting and beyond
  • Assess the emerging role of immunotherapy in CRC

This educational activity is supported by a grant from Merck KGaA, Darmstadt, Germany.

Independent Medical Education (IME)

This IME activity is organized by prIME Oncology. This activity provides content that is evidence-based, balanced, and free of commercial bias, with a primary objective to improve competence and performance of learners in order to improve patient care.

Provider

This activity is provided by prIME Oncology.

Disclosure Information

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure Regarding Unlabeled Use

This activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration or European Medicines Agency. Please refer to the official prescribing information for each product discussed for discussions of approved indications, contraindications, and warnings.